Alibaba Paying $600 Million to Resolve US Drug Sales Probe
Chinese technology and e-commerce giant Alibaba and its U.S.-based payment processor have agreed to pay $600 million to resolve allegations that they failed to prevent illegal drug sales, the U.S. Justice Department said on Wednesday. The companies entered into non-prosecution …
Source: Claims Journal
